Alteogen signs deal with Novartis worth up to 4.4 tln won for subcutaneous formulations Finance · 2026-09-02 07:08:58 Sources Yonhap: Alteogen signs deal with Novartis worth up to 4.4 tln won for subcutaneous formulations